Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021

Date: March 9, 2016
Pages: 209
Price:
US$ 4,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NE58BE5DAA2EN
Leaflet:

Download PDF Leaflet

Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021
The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of the global NGS market in 2016. The NGS market is broadly segmented into products & services, technology, application, and end user. By products & services, the NGS market is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The consumables segment is expected to command the major share of the NGS market, by products& services, in 2016.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global NGS market in 2016, followed by Europe. Asia-Pacific NGS market is poised to witness highest growth rate during the forecast period from 2016 to 2021 due to a number of factors including improving healthcare infrastructure and favorable government initiatives.

Market growth is majorly driven by the technological advancements in NGS products, increasing applications of NGS, entry of new market players, increasing partnerships & collaborations among market players, and growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.

As of 2015, the global NGS market was dominated by Illumina, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); and Pacific Biosciences of California, Inc. (U.S.) which together held a share of 94% of the overall NGS platforms market. New product launches & product enhancements; agreements, collaborations, & partnerships, geographic expansions; strategic acquisitions; and others (offering research fund & grants and organizing conferences/seminars) are the major strategies adopted by most market players to achieve growth in the global NGS market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on NGS products offered by the top 10 players in the NGS market. The report analyzes the NGS market by products & services, technology, application, and end user
  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the NGS market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS devices across four geographies
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the NGS market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Breakdown of primaries
    2.1.2.2 Key data from primary sources
    2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
  2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION

4 PREMIUM INSIGHTS

4.1 GLOBAL NGS MARKET (2016–2021)
4.2 GLOBAL NGS MARKET SHARE, BY PRODUCTS & SERVICES (2016 VS. 2021)
4.3 NGS SEQUENCING SERVICES MARKET, BY APPLICATIONS (2016 VS. 2021)
4.4 GLOBAL NGS TECHNOLOGY MARKET SIZE, BY REGION (2016-2021)

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
  5.2.1 BY PRODUCTS & SERVICES
  5.2.2 BY TECHNOLOGY
  5.2.3 BY APPLICATION
  5.2.4 BY END USER
5.3 MARKET DYNAMICS
  5.3.1 DRIVERS
    5.3.1.1 Technological Advancements in Sequencing Platforms
    5.3.1.2 Increasing Applications of NGS
    5.3.1.3 Growing Partnerships and Collaborations
    5.3.1.4 Research Laboratories and Academicians Promoting NGS
    5.3.1.5 Entry of New Market Players
    5.3.1.6 Conferences and Workshops Increasing Awareness on NGS Products and Services
  5.3.2 RESTRAINTS
    5.3.2.1 Accuracy & Standardization Concerns in Diagnostic Testing
    5.3.2.2 Lack of Skilled Professionals
    5.3.2.3 Ethical and Legal Issues Related to NGS
  5.3.3 OPPORTUNITIES
    5.3.3.1 Personalized Medicine & Biomarker Discovery Open Avenues for the Growth of NGS Market
    5.3.3.2 Emerging Markets Offer Numerous Growth Opportunities
    5.3.3.3 Cloud Computing, a Prospective Service
  5.3.4 CHALLENGES
    5.3.4.1 Interpretation of Complex Data from NGS Platforms
    5.3.4.2 Storage of Sequencing Data
  5.3.5 CURRENT TRENDS
    5.3.5.1 Development of New and Advanced NGS Platforms
    5.3.5.2 Focus on Cancer Research
    5.3.5.3 Mergers and Acquisitions

6 GLOBAL NGS MARKET, BY PRODUCTS & SERVICES

6.1 INTRODUCTION
6.2 PRE-SEQUENCING PRODUCTS & SERVICES
  6.2.1 SAMPLE PREPARATION
    6.2.1.1 DNA Fragmentation, End Repair, A-tailing, and Size Selection
    6.2.1.2 Library Preparation & Target Enrichment
    6.2.1.3 Quality Control
6.3 NGS PLATFORMS, CONSUMABLES, & SERVICES FOR PLATFORMS
  6.3.1 NGS PLATFORMS MARKET
    6.3.1.1 Illumina
      6.3.1.1.1 HiSeq Series
      6.3.1.1.2 HiSeq X Ten & HiSeq X Five
      6.3.1.1.3 MiSeq Series
      6.3.1.1.4 NextSeq500
    6.3.1.2 Thermo Fisher Scientific (Life Technologies)
      6.3.1.2.1 SOLiD Series
      6.3.1.2.2 Ion Torrent Platforms
        6.3.1.2.2.1 Ion PGM
        6.3.1.2.2.2 Ion Proton
        6.3.1.2.2.3 Ion S5 & S5 XL
    6.3.1.3 Pacific Biosciences
      6.3.1.3.1 PacBio RS II
      6.3.1.3.2 Sequel System
    6.3.1.4 Recently Launched Sequencing Platforms
6.4 SEQUENCING SERVICES
  6.4.1 TARGETED RE-SEQUENCING
  6.4.2 RNA-SEQ
  6.4.3 DE NOVO SEQUENCING
  6.4.4 EXOME SEQUENCING
  6.4.5 CHIP-SEQ
  6.4.6 WHOLE-GENOME SEQUENCING
  6.4.7 METHYL-SEQ
  6.4.8 OTHERS
6.5 NGS DATA ANALYSIS, STORAGE, AND MANAGEMENT (BIOINFORMATICS)
    6.5.1.1 NGS Data Analysis Software & Workbenches
    6.5.1.2 NGS Data Analysis Services
    6.5.1.3 NGS Storage, Management, and Cloud Computing Solutions

7 GLOBAL NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

7.1 INTRODUCTION
7.2 SEQUENCING BY SYNTHESIS (SBS)
7.3 ION SEMICONDUCTOR SEQUENCING
7.4 SEQUENCING BY LIGATION (SBL)
7.5 PYROSEQUENCING
7.6 SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
7.7 OTHER TECHNOLOGIES

8 GLOBAL NGS MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 DIAGNOSTICS
8.3 DRUG DISCOVERY
8.4 BIOMARKER DISCOVERY
8.5 PERSONALIZED MEDICINE
8.6 AGRICULTURE & ANIMAL RESEARCH
8.7 OTHER APPLICATIONS

9 NEXT-GENERATION SEQUENCING MARKET, BY END USER

9.1 INTRODUCTION
  9.1.1 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
  9.1.2 HOSPITALS & CLINICS
  9.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.1.4 OTHER END-USERS (NPO, AGRIGENOMICS ORGANIZATIONS, CONSUMER GENOMIC COMPANIES)

10 NEXT GENERATION SEQUENCING MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 U.S.
    10.2.1.1 Favorable government funding scenario in the U.S. market
    10.2.1.2 Growing focus of NGS market players on strengthening their presence in the U.S.
    10.2.1.3 Increasing number of NGS conferences in the U.S.
    10.2.1.4 Increasing focus of laboratories to obtain CLIA certification
  10.2.2 CANADA
    10.2.2.1 Favorable government funding scenario in Canada
    10.2.2.2 Growing focus of market players on expanding their presence in Canada
10.3 EUROPE
  10.3.1 MARKET PLAYERS CAPITALIZING ON OPPORTUNITIES IN THE EUROPEAN NGS MARKET
    10.3.1.1 Launch of new and advanced products and services
    10.3.1.2 Strategic partnerships/agreements/collaborations to develop advanced techniques
  10.3.2 GERMANY, U.K., AND BELGIUM: MAJOR HUBS FOR SCIENTIFIC RESEARCH
  10.3.3 GROWING FUNDING AND INVESTMENTS FOR NGS IN EUROPE
10.4 ASIA-PACIFIC
  10.4.1 GROWING FOCUS OF DOMESTIC AND MULTINATIONAL PLAYERS ON APAC MARKET
    10.4.1.1 Launch of advanced NGS products and services
    10.4.1.2 Partnerships/collaborations/agreements to co-develop advanced NGS products and services
  10.4.2 FAVORABLE GOVERNMENT FUNDING SCENARIO IN SEVERAL ASIA-PACIFIC COUNTRIES
  10.4.3 GROWTH IN THE NUMBER OF CONFERENCES/SEMINARS/TRAINING PROGRAMS IN THE ASIA-PACIFIC REGION
10.5 REST OF THE WORLD (ROW)
  10.5.1 FOCUS OF KEY MARKET PLAYERS ON EXPANDING THEIR PRESENCE IN THE REST OF THE WORLD REGION
  10.5.2 GROWING NUMBER OF WORKSHOPS AND CONFERENCES
  10.5.3 IMPLEMENTATION OF FAVORABLE INITIATIVES BY PUBLIC AND PRIVATE ORGANIZATIONS

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SITUATION AND TRENDS
  11.3.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
  11.3.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS
  11.3.3 MERGERS AND ACQUISITIONS
  11.3.4 GEOGRAPHIC EXPANSIONS
  11.3.5 OTHER DEVELOPMENTS

12 COMPANY PROFILES

12.1 INTRODUCTION
  12.1.1 GEOGRAPHIC BENCHMARKING
12.2 ILLUMINA, INC.
12.3 THERMO FISHER SCIENTIFIC, INC.
12.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
12.5 BEIJING GENOMICS INSTITUTE
12.6 QIAGEN N.V.
12.7 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
12.8 AGILENT TECHNOLOGIES, INC.
12.9 EUROFINS SCIENTIFIC
12.10 GATC BIOTECH AG
12.11 MACROGEN INC.
12.12 OXFORD NANOPORE TECHNOLOGIES, LTD.
12.13 PERKINELMER, INC.

13 APPENDIX

13.1 DISCUSSION GUIDE*
13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS

LIST OF TABLES

Table 1 NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 2 NGS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 3 PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 4 PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 DNA FRAGMENTATION, END REPAIR, A-TAILING, & SIZE SELECTION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 6 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 7 QUALITY CONTROL MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 8 NGS INSTRUMENTS, CONSUMABLES, AND SERVICES MARKET SIZE, 2014–2021 (USD MILLION)
Table 9 NGS PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 10 CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 SERVICES FOR SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 ILLUMINA NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 13 ILLUMINA NGS PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 HISEQ SERIES PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 HISEQ X TEN & HISEQ X FIVE PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 MISEQ SERIES PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 NEXTSEQ 500 PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 19 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 SOLID SERIES PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 ION PGM PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 ION PROTON PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 ION S5 & S5 XL PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 25 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 PACBIO RS II PLATFORMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 SEQUEL SYSTEM MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 29 SEQUENCING SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 30 TARGETED SEQUENCING/GENE PANELS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 31 RNA-SEQ MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 32 DE NOVO SEQUENCING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 33 EXOME SEQUENCING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 CHIP-SEQ MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 WHOLE-GENOME SEQUENCING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 36 METHYL-SEQ MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 37 OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 38 NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 39 NGS BIOINFORMATICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 40 DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 41 DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 42 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
Table 43 GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 44 SEQUENCING BY SYNTHESIS (SBS) MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 45 ION SEMICONDUCTOR SEQUENCING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 46 SEQUENCING BY LIGATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 47 PYROSEQUENCING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 48 SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 49 GLOBAL NGS MARKET, BY APPLICATION, 2014–2021 (USD MILLION)
Table 50 DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 51 DRUG DISCOVERY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 52 BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 53 PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 54 AGRICULTURE AND ANIMAL RESEARCH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 55 OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 56 GLOBAL NGS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 57 RESEARCH CENTERS, ACADEMIC/GOVERNMENT INSTITUTES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 58 HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 59 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 60 OTHER END USERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 61 NGS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 62 NORTH AMERICA: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 63 NORTH AMERICA: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 64 NORTH AMERICA: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 65 NORTH AMERICA: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 66 NORTH AMERICA: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 67 NORTH AMERICA: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 68 NORTH AMERICA: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 69 NORTH AMERICA: NGS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 70 NORTH AMERICA: NGS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 71 NORTH AMERICA: NGS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 72 EUROPE: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 73 EUROPE: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 74 EUROPE: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 75 EUROPE: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 76 EUROPE: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 77 EUROPE: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 78 EUROPE: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 79 EUROPE: NGS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 80 EUROPE: NGS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 81 EUROPE: NGS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 82 ASIA-PACIFIC: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 83 ASIA-PACIFIC: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 84 ASIA-PACIFIC: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 85 ASIA-PACIFIC: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 86 ASIA-PACIFIC: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 87 ASIA-PACIFIC: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 88 ASIA-PACIFIC: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 89 ASIA-PACIFIC: NGS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 90 ASIA-PACIFIC: NGS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 91 ASIA-PACIFIC: NGS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 92 ROW: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 93 ROW: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 94 ROW: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 95 ROW: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 96 ROW: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014–2021 (USD MILLION)
Table 97 ROW: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 98 ROW: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014–2021 (USD MILLION)
Table 99 ROW: NGS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 100 ROW: NGS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 101 ROW: NGS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 102 TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013–2015
Table 103 TOP 5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS, 2013–2015
Table 104 TOP MERGERS AND ACQUISITIONS, 2013–2015
Table 105 TOP GEOGRAPHIC EXPANSIONS, 2013–2015
Table 106 TOP 5 OTHER DEVELOPMENTS, 2013–2015

LIST OF FIGURES

Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 NGS MARKET: BOTTOM-UP APPROACH
Figure 4 NGS MARKET: TOP-DOWN APPROACH
Figure 5 NGS MARKET: DATA TRIANGULATION
Figure 6 GLOBAL NGS MARKET, BY APPLICATION, 2016 (USD MILLION)
Figure 7 GLOBAL NGS PLATFORMS MARKET, 2016 VS. 2021
Figure 8 GLOBAL NGS MARKET, BY REGION, 2016 (USD MILLION)
Figure 9 ATTRACTIVE GROWTH OPPORTUNITIES IN THE NGS MARKET
Figure 10 PRE-SEQUENCING PRODUCTS & SERVICES SEGMENT IS EXPECTED TO GAIN MARKET SHARE IN 2021
Figure 11 METHYL-SEQ AND DE NOVO SEQUENCING IS EXPECTED TO GROW AT HIGHER CAGR FROM 2016 TO 2021
Figure 12 SEQUENCING BY SYNTHESIS TO COMMAND THE LARGEST SHARE OF THE NGS TECHNOLOGIES IN 2016
Figure 13 NGS MARKET, BY PRODUCTS & SERVICES
Figure 14 NGS MARKET, BY TECHNOLOGY
Figure 15 NGS MARKET, BY APPLICATION
Figure 16 NGS MARKET, BY END USER
Figure 17 NGS MARKET DYNAMICS
Figure 18 LIST OF SEQUENCING PLATFORMS LAUNCHED BY MARKET PLAYERS IN 2015-2016
Figure 19 NEW MARKET PLAYERS AND THEIR SEQUENCING PLATFORMS
Figure 20 TECHNOLOGICAL ADVANCEMENTS TO INCREASE ADOPTION OF NGS PLATFORMS
Figure 21 LACK OF SKILLED TECHNICIANS HINDERS THE NGS MARKET GROWTH
Figure 22 PERSONALIZED MEDICINE & BIOMARKER DISCOVERY OPEN AVENUES FOR THE GROWTH OF NGS MARKET
Figure 23 DATA STORAGE AND INTERPRETATION ARE MAJOR CONCERNS OF NGS MARKET
Figure 24 MAJOR ACQUISITIONS IN THE NGS MARKET
Figure 25 SMRT SEQUENCING IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING 2016 TO 2021
Figure 26 DIAGNOSTICS SEGMENT TO HOLD LARGEST SHARE IN THE MARKET DURING 2016-2021
Figure 27 HOSPITALS & CLINICS END USER SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 28 GLOBAL NGS MARKET OVERVIEW
Figure 29 NORTH AMERICAN NGS MARKET SNAPSHOT
Figure 30 EUROPEAN NGS MARKET SNAPSHOT
Figure 31 ASIA-PACIFIC NGS MARKET SNAPSHOT
Figure 32 ROW NGS MARKET SNAPSHOT
Figure 33 LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST THREE YEARS (2013–2015)
Figure 34 GLOBAL NGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
Figure 35 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS* (2014)
Figure 36 ILLUMINA, INC.: COMPANY SNAPSHOT
Figure 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
Figure 38 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT
Figure 39 QIAGEN N.V.: COMPANY SNAPSHOT
Figure 40 ROCHE HOLDING AG: COMPANY SNAPSHOT
Figure 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
Figure 42 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
Figure 43 MACROGEN INC.: COMPANY SNAPSHOT
Figure 44 PERKINELMER, INC.: COMPANY SNAPSHOT
Skip to top


Ask Your Question

Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: